Diabetes startup Bigfoot Biomedical hauls in $55 mln Series B
Diabetes startup Bigfoot Biomedical Inc, has raised $55 million in Series B financing. The investors included Abbott, Cormorant Asset Management, Senvest Capital Inc., Senvest Management LLC, Visionnaire Ventures, JDRF T1D Fund and T1D Exchange.
28 March 2018•1 min read
